PROSTATE CANCER Challenges in selecting the optimal therapy

被引：2
作者：
Zelefsky, Michael J. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA
来源：
NATURE REVIEWS UROLOGY | 2012年 / 9卷 / 12期
关键词：
D O I：
10.1038/nrurol.2012.193
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The plethora of treatment options available for localized prostate cancer can make the patient's decision regarding which therapy to undergo a difficult one. A recent study has investigated the effect of using a decision aid to provide patients with enough information to make an informed decision about their therapy.
引用
收藏
页码：674 / 676
页数：4
相关论文
共 50 条
  • [41] Prostate cancer and therapeutic challenges
    Hawsawi, Yousef MohammedRabaa
    Zailaie, Samar Abdullah
    Oyouni, Atif Abdulwahab A.
    Alzahrani, Othman Rashed
    Alamer, Osama Mohamed
    Aljohani, Saad Ali S.
    JOURNAL OF BIOLOGICAL RESEARCH-THESSALONIKI, 2020, 27 (01)
  • [42] Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy
    Barqawi, Al B.
    Krughoff, Kevin J.
    Eid, Khadijah
    ADVANCES IN UROLOGY, 2012, 2012
  • [43] Transperineal 3D mapping biopsy of the prostate: An essential tool in selecting patients for focal prostate cancer therapy.
    Ukimura, Osamu
    JOURNAL OF ENDOUROLOGY, 2009, 23 (02) : 221 - 222
  • [44] PSMA radioligand therapy in prostate cancer: overview, latest advances and remaining challenges
    Sachpekidis, Christos
    Alberts, Ian
    Rominger, Axel
    Afshar-Oromieh, Ali
    IMMUNOTHERAPY, 2019, 11 (15) : 1267 - 1271
  • [45] Optimal chemotherapy for prostate cancer
    Papandreou, Christos N.
    ANNALS OF ONCOLOGY, 2004, 15 : 8 - 8
  • [46] Men's Perspectives on Selecting Their Prostate Cancer Treatment
    Xu, Jinping
    Dailey, Rhonda K.
    Eggly, Susan
    Neale, Anne Victoria
    Schwartz, Kendra L.
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2011, 103 (06) : 468 - 478
  • [47] On selecting mRNA isoform features for profiling prostate cancer
    Nair, T. Murlidharan
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2009, 33 (06) : 421 - 428
  • [48] Selecting patients for prostate cancer treatment: the role of comorbidity
    Wallis, Christopher J. D.
    Satkunasivam, Raj
    Bhindi, Bimal
    BJU INTERNATIONAL, 2018, 121 (02) : 164 - 165
  • [49] Combined androgen blockade: an optimal therapy for minimally advanced prostate cancer? Commentary
    Kirk, D
    BRITISH JOURNAL OF UROLOGY, 1998, 81 (01): : 94 - 95
  • [50] Toward the optimal use of androgen suppression therapy in the radiotherapeutic management of prostate cancer
    D'Amico, Anthony V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) : 8 - 9
12345